Direct Biologics is committed to providing the latest information on exosome scientific and clinical research. ExoFlo is an exosome allograft product isolated from bone marrow-derived MSCs that provides multiple regulatory proteins.
What are ExoFlo™ Exosomes?
Involved in cell to cell communication
Natural signals with no preservatives
Approximately 30nm – 150nm in size
ExoFlo is an allograft exosome product derived from bone marrow-derived mesenchymal stem cells (MSCs) that carries signaling proteins that modulate inflammation. Involved in cell-to-cell communication: Natural signals with no preservatives, Approximately 30nm – 150nm
The extensive intellectual property surrounding proprietary methods for obtaining concentrated growth factors and exosomes from human mesenchymal stem cells and their utility have made Direct Biologics a leader in therapeutic innovation around this ground breaking new technology.
More than 1,000 regulatory proteins
• Anti-inflammatory cytokines
• Angiogenic growth factors
• Anti-tumor signals
• Inhibitors of apoptosis
Messenger RNA (mRNA)
Translated by recipient cells into new proteins that can regulate inflammatory cells and new vessel formation
Micro RNA (miRNA) – OFF Switch
May inhibit mRNA of chronic inflammatory cytokines and matrix catabolic enzymes
Exosomes Are Not Small Cells
- ~1/1,000 the size of a cell
- Do not have a nucleus
- Cannot replicate
- Do not have metabolic activity
Contact your local Direct Biologics representative – Physician product information – Patient Education resources
Write us with questions or for the following information: contact your local Direct Biologics representative, physician product information, Patient Education resources
All rights reserved © Copyright 2019